Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.93) by 4.15 percent. This is a 33 percent increase over losses of $(3.00) per share from the same period last year.
Investor Optimism Improves After US Stocks Record Weekly Gains
The CNN Money Fear and Greed index showed slight improvement in overall sentiment among U.S. investors on Friday.
U.S. stocks closed lower on Friday after Republicans withdrew from debt ceiling negotiations, declaring the discussions to be at an impasse.
